Abstract
Autoimmune haemolytic anaemia (AIHA) and paroxysmal nocturnal haemoglobinuria (PNH) are two distinct causes of haemolytic anaemia. They have different mechanisms that underpin their pathogenesis and, therefore, require different treatment strategies. The direct antiglobulin test (DAT) or Coombs’ test is positive in cases of immune-mediated haemolytic anaemia and, thus, is positive in AIHA but negative in PNH. We report a case of a man presenting with a haemolytic anaemia who was found to have concomitant evidence of AIHA and PNH. The case highlights the importance of carrying out a comprehensive haemolysis work-up in patients who present with haemolytic anaemia.
Publisher
Haematology Society of Bangladesh
Reference6 articles.
1. Saxena R, Pati HP, Mahapatra M. De Gruchy's Clinical Haematology in Medical Practice. 6th ed. New Delhi: Wiley; 2013.
2. Hoffbrand AV, Moss PAS. Essential Haematology. 6th ed. Wiley-Blackwell; 2013.
3. Takeda J, Miyata T, Kawagoe K, Iida Y, Endo Y, Fujita T et al. Deficiency of the GPI anchor caused by a somatic mutation of the PIG-A gene in paroxysmal nocturnal haemoglobinuria. Cell. 1993; 73:703–11.
4. Hill A, Rother RP, Arnold L, et al. Eculizumab prevents intravascular haemolysis in patients with paroxysmal nocturnal haemoglobinuria and unmasks low-level extravascular haemolysis occurring through C3 opsonization. Haematologica 2010 Apr; 95(4):567–73.
5. Sutherland DR, Kuek N, Azcona-Olivera J, et al. Use of a FLAER-based WBC assay in the primary screening of PNH clones. Am J Clin Pathol 2009; 132:564–72.